LumiraDx Limited (LMDXF)
OTCMKTS: LMDXF · Delayed Price · USD
0.0005
0.00 (0.00%)
Jul 23, 2024, 4:00 PM EDT - Market closed
LumiraDx Employees
LumiraDx had 1,210 employees as of December 31, 2022. The number of employees decreased by 303 or -20.03% compared to the previous year.
Employees
1,210
Change (1Y)
-303
Growth (1Y)
-20.03%
Revenue / Employee
$104,558
Profits / Employee
-$279,368
Market Cap
493.01M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 1,210 | -303 | -20.03% |
| Dec 31, 2021 | 1,513 | 303 | 25.04% |
| Dec 31, 2020 | 1,210 | 1,208 | 60,400.00% |
| Dec 31, 2017 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
LMDXF News
- 7 months ago - LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th - GlobeNewsWire
- 7 months ago - Roche to buy part of LumiraDx diagnostics platform for $295 million - Reuters
- 7 months ago - LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche - GlobeNewsWire
- 9 months ago - LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal - GlobeNewsWire
- 9 months ago - Top 4 Health Care Stocks That May Rocket Higher This Month - Generation Bio (NASDAQ:GBIO), Evelo Biosciences (NASDAQ:EVLO) - Benzinga
- 11 months ago - LumiraDx Reports Second Quarter 2023 Results - GlobeNewsWire
- 1 year ago - LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24 - GlobeNewsWire
- 1 year ago - LumiraDx's Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests - GlobeNewsWire